<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1 INDICATIONS AND USAGE<BR>               <BR>                  Enter section text here<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Fluoxetine is a selective serotonin reuptake inhibitor indicated <BR>for: <BR>                        <BR>                           Acute and maintenance treatment of major depressive disorder (MDD) in adult <BR>and pediatric patients aged 8 to 18 years. (1.1) <BR>                           Acute and maintenance treatment of obsessive compulsive disorder (OCD) in <BR>adult and pediatric patients aged 7 to 17 years. (1.2) <BR>                           Acute and maintenance treatment of bulimia nervosa in adult patients. (1.3) <BR>                           Acute treatment of panic disorder, with or without agoraphobia, in adult <BR>patients. (1.4)<BR>                        <BR>                        <BR>                           Fluoxetine and olanzapine in combination for:<BR>                        <BR>                           Acute treatment of depressive episodes associated with bipolar I disorder in <BR>adults. (1.5) <BR><BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.1 Major Depressive Disorder<BR>                     <BR>                        Fluoxetine capsules are indicated for the acute and maintenance <BR>treatment of major depressive disorder in adult patients and in pediatric <BR>patients aged 8 to18 years [see Clinical Studies <BR>(14.1)]. <BR>                        The usefulness of the drug in adult and pediatric patients receiving <BR>fluoxetine for extended periods, should periodically be reevaluated [see  <BR>                                 Dosage and <BR>Administration (2.1)<BR>                              ].<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.2 Obsessive Compulsive Disorder<BR>                     <BR>                        Fluoxetine capsules are indicated for the acute and maintenance <BR>treatment of obsessions and compulsions in adult patients and in pediatric <BR>patients aged 7 to 17 years with obsessive compulsive disorder (OCD) [see Clinical Studies <BR>(14.2)].<BR>                        <BR>                        The effectiveness of fluoxetine in long-term use, i.e., for more than 13 <BR>weeks, has not been systematically evaluated in placebo-controlled trials. <BR>Therefore, the physician who elects to use fluoxetine capsules for extended <BR>periods, should periodically reevaluate the long-term usefulness of the drug for <BR>the individual patient [see <BR>                                 Dosage and <BR>Administration (2.2)<BR>                              ].<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.3 Bulimia Nervosa<BR>                     <BR>                        Fluoxetine capsules are indicated for the acute and maintenance <BR>treatment of binge-eating and vomiting behaviors in adult patients with moderate <BR>to severe bulimia nervosa [see Clinical Studies <BR>(14.3)]. <BR>                        The physician who elects to use fluoxetine capsules for extended periods <BR>should periodically reevaluate the long-term usefulness of the drug for the <BR>individual patient [see Dosage and <BR>Administration (2.3)]. <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.4 Panic Disorder<BR>                     <BR>                        Fluoxetine capsules are indicated for the acute treatment of <BR>panic disorder, with or without agoraphobia, in adult patients [see Clinical Studies <BR>(14.4)].<BR>                        <BR>                        The effectiveness of fluoxetine in long-term use, i.e., for more than 12 <BR>weeks, has not been established in placebo-controlled trials. Therefore, the <BR>physician who elects to use fluoxetine capsules for extended periods, should <BR>periodically reevaluate the long-term usefulness of the drug for the individual <BR>patient [see  <BR>                                 Dosage and <BR>Administration (2.4)<BR>                              ].<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.5 Fluoxetine and Olanzapine in Combination: Depressive Episodes Associated with Bipolar I Disorder<BR>                     <BR>                        <BR>                        <BR>                           <BR>                              When using fluoxetine and olanzapine in combination, also refer to <BR>the Clinical Studies section of the package insert for Symbyax®. <BR>                           <BR>                        <BR>                        <BR>                            <BR>                            <BR>Fluoxetine and olanzapine in combination is indicated for the acute treatment of <BR>depressive episodes associated with bipolar I disorder in adult patients. <BR><BR>                        <BR>                        <BR>                            <BR>                            <BR>Fluoxetine capsule monotherapy is not indicated for the treatment of depressive <BR>episodes associated with bipolar I disorder.<BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>